Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Bone remodeling assessment after total hip replacement].

A Georges1, N Barthe, F Castaing

  • 1Service de médecine nucléaire, CHU de Bordeaux Hôpital Haut-Lévêque, Avenue Magellan, 33604 Pessac cedex, France.

Annales De Biologie Clinique
|November 26, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nature of Metallic and Insulating Domains in the Charge-Density-Wave System 1T-TaSe_{2}.

Physical review letters·2025
Same author

Fate of Quasiparticles at High Temperature in the Correlated Metal Sr_{2}RuO_{4}.

Physical review letters·2023
Same author

Mott insulators with boundary zeros.

Nature communications·2023
Same author

Distinct spin and orbital dynamics in Sr<sub>2</sub>RuO<sub>4</sub>.

Nature communications·2023
Same author

[Long-duration home hospitalization: the impacts of socio-demographic and clinical factors and care pathways].

Revue d'epidemiologie et de sante publique·2022
Same author

Absence of relationships between depression and anxiety and bone mineral density in patients hospitalized for severe anorexia nervosa.

Eating and weight disorders : EWD·2020
Same journal

[The role of the heart-on-a-chip to drug evaluation].

Annales de biologie clinique·2026
Same journal

A morphology-driven proof-of-concept study linking interphase nuclear abnormalities to dicentric-mediated genomic instability.

Annales de biologie clinique·2026
Same journal

Analytical validation and clinical concordance of Diazyme free light chain assays on the Cobas® platform compared with Freelite™.

Annales de biologie clinique·2026
Same journal

Small-cell secondary plasma cell leukemia mimicking low-grade B-cell lymphoma.

Annales de biologie clinique·2026
Same journal

[Multiple myeloma and analytical discrepancy in serum free light chain assay: a case report].

Annales de biologie clinique·2026
Same journal

[Summary of the 34th National Conference of the National College of Hospital Biochemistry].

Annales de biologie clinique·2026
See all related articles

Total hip arthroplasty (THA) can cause bone loss. This study found that urinary deoxypyridinoline (uDPYR), a bone resorption marker, did not correlate with periprosthetic bone mineral density (BMD) changes measured by DEXA over two years post-surgery.

Area of Science:

  • Orthopedic surgery
  • Biomedical engineering
  • Bone metabolism

Context:

  • Total hip arthroplasty (THA) is associated with adaptive bone remodeling and periprosthetic bone loss.
  • Dual-energy X-ray absorptiometry (DEXA) is the gold standard for measuring bone mineral density (BMD).
  • Urinary deoxypyridinoline (uDPYR) is a validated marker for bone resorption.

Purpose:

  • To compare DEXA-measured periprosthetic BMD with urinary deoxypyridinoline (uDPYR) levels over two years following total hip arthroplasty (THA).
  • To evaluate the utility of a urinary bone resorption marker in monitoring periprosthetic bone remodeling after THA.

Summary:

  • This study monitored 41 patients undergoing cemented THA for two years, measuring periprosthetic BMD via DEXA and urinary uDPYR levels.

Related Experiment Videos

  • uDPYR significantly decreased from post-operation to one year but showed no significant change between years one and two.
  • Periprosthetic BMD initially decreased but showed regional recovery over two years, with distal regions recovering more than proximal regions.
  • A discrepancy was observed between uDPYR and BMD results, indicating uDPYR is not suitable for monitoring local bone remodeling post-THA.

    • Impact:

    • Findings suggest that urinary bone resorption markers like uDPYR may not accurately reflect localized periprosthetic bone remodeling dynamics after THA.
    • This highlights the need for continued investigation into reliable methods for monitoring bone health in the vicinity of hip implants.
    • Understanding periprosthetic bone changes is crucial for improving implant longevity and patient outcomes.